I have 2. The first one is a follow-up in the margins. I understood the message that you should kind of stabilize or even improve a little bit from the current levels. But I have some doubt here regarding first, the overdue loans have increased, as I said, right, like the nonaccrual loans only pay for the increase. In the next quarter, in pricing, it's probably in 2021, in the first quarter in 2021. And you also have a new government program that I understood maybe the incumbent can be super vocal in the program because, again, you have a lot of renegotiations already, the size of the guarantee is not that big. But should that should be a headwind on margins, right? So I just would like to confirm that, yes, margins should move slightly up from the current levels and that we are taking consideration through -- in all moving parts, the nonaccrual loans and also the renegotiated program. And my second question is regarding allowances. I understand the charge-offs are not there, right, charge-offs need to accelerate. But you are in Latin America, the bank is the biggest delta in allowances, right. Allowance has almost doubled versus 2019 on your balance sheet. You have, I don't know, PEN 4.6 billion, PEN 4.7 billion in higher allowances than you had last year. And so far, the data in reprogrammation like in the release -- I think in the second half, you're okay, right? We have a 94% collection in BCP, 84% collection in bank renegotiated loans are coming down from the fee. So the point is how do we discuss 2021 reversions of those provisions not only a lower cost of risk structurally, but I don't know, the bank, the kind of reverting those provisions at some point.